VRTX
Vertex Pharmaceuticals Inc
Price:  
488.12 
USD
Volume:  
1,472,767.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex Probability of Bankruptcy

The Probability of Bankruptcy of Vertex Pharmaceuticals Inc (VRTX) is 1.32% . This number represents the probability that Vertex will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating Vertex's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

Vertex - ESG ratings

ESG ratings are directly linked to the cost of capital and Vertex's ability to raise funding, both of which can significantly affect the probability of Vertex Pharmaceuticals Inc going bankrupt.

ESG Score 80.00
Environment Score 83.75
Social Score 99.00
Governance Score 57.25
Returns
Historical Returns (5 day) -0.13%
Historical Returns (MTD) 4.14%
Historical Returns (YTD) 19.96%
Historical Returns (13 week) 23.83%
Historical Returns (26 week) 13.50%
Historical Returns (52 week) 36.13%
Efficiency
Asset Turnover 0.46
Receiveable Turnover 6.10
Gross Margin 87.27%
Operating Margin 42.35%
Pretax Margin 47.54%
Net Margin 40.87%
Return on Asset (ROA) 18.12
Return on Equity (ROE) 23.61
Return on Investments (ROI) 23.09
Price Metrics
Market Cap (M) 125,959.37
Enterprise Value (M)
52 Week High 496.93
52 Week Low 340.20
Beta 0.91
Average Volume (10 day) 0.98
Average Volume (3 month) 1.11
Price / Earnings (P/E) 31.28
Price / Sales (P/S) 12.35
Earnings
EPS 15.42
Revenue CAGR (5 year) 26.49%
Risk
Current Ratio 3.50
Quick Ratio 3.16